Venkat has to get the ball rolling for one very important fact-with
Pharmaceutical companies-drug delivery changes and so does
effectiveness ratios. In English- products need to capitalize on
their uniqueness because changes happen to how drugs are
molecularly constructed. Three companies can be attempting
to produce a drug for ackne etc. The person that delivers an
effective product can start to carve out a niche. They also can
have years of market penetration that allows them the money
to plow back into R&D for that product to keep it superior..
WAITING DOES NOTHING BUT LET YOUR COMPETITION
BEAT YOU TO THE MULA $$$$$$ So, he has to get phase
3 either financed or the stock going to allow him to capitalize
on the market …..
Also stock allows him to drive up the pps up to gain recognition
from institutions who have the capital to invest in VYOM-thus
letting Venkat bring other products to market.
Interesting will be volume next week, the price is right
wheel is moving again, at least one full rotation now past 1.00
dollar. Once we get 500k days again or a couple wheel rotations
I’ll get some inclination news could be coming.
It’s the chicken or the egg theory here but with a twist. Venkat
Needs a ticker change stating his company-assets in the shell
assigned to VYOM, and a company intro pr-BEFORE he can
interest institutions…..No stock, no future investment into his
company……it’s that simple- START the race or get lapped-that
easy.
So with the Nevada filing/filings-maybe iit will soon change from
red light to green..
Getting interesting again…..let’s continue with some MO-mo
TS
